Abigail Sutton on Muck Rack

Abigail Sutton

Verified
United States
As seen in: WebMD, Healio, Healio Cardiac/Vascular Intervention, Healio Ophthalmology, JD Supra, Primary Care Optometry News, Healio Dermatology
I love fishing and camping I'm a senior at MCC snapchat-Abigail1111222 Instagram-fun_abbysutton
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Abigail

Contact Abigail, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Medicaid Planning in Tennessee: Why Early Action is Critical | JD Supra

|
By Abigail Sutton Verified
| JD Supra
Protecting tour assets while ensuring access to essential long-term care coverage. The statistics are sobering — more than 70% of Americans over age 65 will need some form of long-term care during their lifetime, with costs in Tennessee averaging $8,580 per month for nursing home care and climbing annually. For most families, these expenses quickly exhaust life savings, making Medicaid eligibility essential for accessing quality care while preserving some family wealth.
Open in Who Shared Issue with article?

A Standardized Hand-off Tool for Undergraduate Nursing Students

|
By Abigail Sutton Verified, Stacie Hunsaker, Brigham Young
| scholarsarchive.byu.edu
Home > JUR > Vol. 2018 (2018) > Iss. 1 standardized hand-off tool, undergraduate nursing students, patient safety Sutton, Abigail and Hunsaker, Stacie (2018) "A Standardized Hand-off Tool for Undergraduate Nursing Students," Journal of Undergraduate Research: Vol. 2018: Iss. 1, Article 185. Available at: https://scholarsarchive.byu.edu/jur/vol2018/iss1/185 COinS
Open in Who Shared Issue with article?

FDA Grants Orphan Drug Designation Epcoritamab for Follicular Lymphoma

|
By Abigail Sutton Verified
| mdalert.com
By Abigail Sutton, Managing Editor Save to PDF April 4, 2022 By <em>By Abigail Sutton, Managing Editor</em> Epcoritamab received orphan drug designation from the FDA for the treatment of follicular lymphoma, according to a press release from the manufacturer. The drug is an investigational IgG1-bispecific antibody using proprietary technology “to direct cytotoxic T cells selectively to tumors to cause an immune response towards malignant cells,” according to the release.
Open in Who Shared Issue with article?
See all 175 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified